<div id="readability-page-1"><div><p>Investors were disappointed with the weak earnings posted by <strong>Herbalife Ltd.</strong> (NYSE:HLF ).  However, our analysis suggests that the soft headline numbers are getting counterbalanced by some positive underlying factors.</p><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p><figure><img height="1120" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/9938532-earnings-and-revenue-history-1-dark-2/1779216097993?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1642" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/9938532-earnings-and-revenue-history-1-dark-2/1779216097993"/><figcaption>NYSE:HLF Earnings and Revenue History May 19th 2026</figcaption></figure> <h2> Zooming In On Herbalife's Earnings </h2><p> As finance nerds would already know, the <strong>accrual ratio from cashflow</strong> is a key measure for assessing how well a company's free cash flow (FCF) matches its profit.  In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period.  This ratio tells us how much of a company's profit is not backed by free cashflow. </p><p> As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative.  That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high.  To quote a 2014 paper by Lewellen and Resutek, &#34;firms with higher accruals tend to be less profitable in the future&#34;. </p><p> Over the twelve months to March 2026, Herbalife recorded an accrual ratio of -0.12.   That indicates that its free cash flow was a fair bit more than its statutory profit.    To wit, it produced free cash flow of US$374m during the period, dwarfing its reported profit of US$239.8m.    Herbalife shareholders are no doubt pleased that free cash flow improved over the last twelve months.  </p><p> That might leave you wondering what analysts are forecasting in terms of future profitability.  Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.  </p> <h2>Our Take On Herbalife's Profit Performance</h2><p> As we discussed above, Herbalife has perfectly satisfactory free cash flow relative to profit.      Because of this, we think Herbalife's earnings potential is at least as good as it seems, and maybe even better!     On the other hand, its EPS actually shrunk in the last twelve months.     Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors.     If you want to do dive deeper into Herbalife, you'd also look into what risks it is currently facing.    Case in point: We've spotted <strong>3 warning signs for Herbalife</strong> you should be mindful of and 2 of these are significant.   </p><p> This note has only looked at a single factor that sheds light on the nature of Herbalife's profit.   But there are plenty of other ways to inform your opinion of a company.  For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying.  While it might take a little research on your behalf, you may find this <strong>free</strong>  collection of companies boasting high return on equity, or  this list of stocks with significant insider holdings to be useful.  </p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Herbalife might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

<p>Herbalife Ltd. (NYSE:HLF) reported disappointing earnings, but analysis reveals positive underlying factors, including a negative accrual ratio of -0.12, indicating strong free cash flow of $374m compared to a profit of $239.8m. Despite a decline in EPS, the company's earnings potential appears solid. Investors are advised to consider various factors, including risks and return on equity, for a comprehensive evaluation.</p>

Simplywall

Investors Can Find Comfort In Herbalife's (NYSE:HLF) Earnings Quality